Halozyme blocks Merck

Halozyme wins court order to block Merck's injected Keytruda in select European markets

A Dutch patent court ruled in favor of Halozyme against Merck, ordering the halt of injectable Keytruda sales in eight European markets due to infringement on Halozyme's MDASE delivery technology. Thi